Navigation Links
Allotrope Foundation partners with Osthus Inc. to develop state-of-the-art open framework for laboratory data
Date:9/23/2013

WASHINGTON, Sept. 23, 2013 /PRNewswire-USNewswire/ -- Allotrope Foundation – a consortium of leading pharmaceutical and biotech companies – selected Osthus Inc. as the architect of its much anticipated open framework for laboratory data. The scope of services that Osthus will provide includes consulting services to Allotrope, as well as the design, coding and implementation of the framework.

"During the comprehensive and rigorous RFP process, Osthus Inc. kept impressing us with their innovative ideas and intelligent solutions for realizing the concept of Allotrope's framework," said Gordon Hansen, Vice President, Analytical Development at Boehringer Ingelheim and Chair, Board of Directors at Allotrope. "We are excited about the partnership with Osthus Inc. and working together to build the foundation for the intelligent analytical laboratory."

"We look forward to working with Allotrope's innovative and highly motivated members to create a common framework that will move life science companies and their vendors forward by innovating faster and more cost-effectively, while complying with government requirements more easily," said Dr. Torsten Osthus, President of Osthus Inc., and Managing Director of Osthus GmbH. "Osthus Inc. is all about transforming research complexity into decision-making knowledge and process efficiency. Allotrope's framework is an important stepping-stone designed to facilitate that. We are proud to be part of this project."

At a recent one-week workshop in Washington D.C., the development of the framework got underway, starting with joint design and requirement research.

About Allotrope Foundation:
Allotrope Foundation is an international consortium of pharmaceutical companies that is developing an innovative, open framework for managing analytical data throughout its complete lifecyc
'/>"/>

SOURCE Allotrope Foundation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Partnerschaft zwischen Allotrope Stiftung und Osthus Inc. zur Entwicklung eines hochmodernen offenen Frameworks für Labordaten
2. Chicago Mayor Rahm Emmanuel and Illinois Governor Patrick Quinn Recognize Brain Research Foundations 60th Anniversary
3. Avon Foundation for Women, NIH, and the Center for Advancing Innovation Launch Start-Up Challenge to Advance Breast Cancer Biomedical Invention
4. The tranSMART Foundation Announces New Version of the tranSMART Open Source Data Sharing Platform for the Life Sciences Community
5. Rhythm Awarded $1.35 Million from The Michael J. Fox Foundation to Advance Clinical Development of RM-131 for Refractory Constipation in Parkinsons Disease
6. Wayne State receives National Science Foundation grant for training future nanoengineers
7. The Galien Foundation Celebrates Biomedical Innovation in Fourth Galien Forum
8. The Sidney Kimmel Foundation for Cancer Research Announces 2013 Grant Recipients
9. OU professor recipient of grant from the Simons Foundation Fellows Program in Theoretical Physics
10. The Research Foundation for The State University of New York Enters Site License Agreement with 2Market Information Inc., Publisher of Technology Transfer Tactics
11. Wysebridge Patent Bar Review Supports the National Foundation for Celiac Awareness (NFCA) During Celiac Awareness Month
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... Pipette.com announces their Holiday in ... submit their #HolidayInTheLab pictures for a chance to win ... For those struggling to think of a holiday gift ... the Lab Contest provides the ideal holiday presents. The ... send pictures of their chemistree, holiday sweaters, as well ...
(Date:12/24/2014)... -- Rock Creek Pharmaceuticals, Inc., (NASDAQ: RCPI ) ... Application (CTA) with the United Kingdom,s ... approval to initiate clinical trials for the continued development ... on the Company receiving CTA regulatory approval, the Company ... the safety, tolerability and dose escalation of Anatabine Citrate ...
(Date:12/22/2014)... CHAPEL HILL, N.C. , Dec. 22, 2014 ... ALNE) today announced that it has signed a ... biotechnology company that has developed and patented a ... and medical diagnostics products that enable rapid on-site ... and alcohol use/abuse and health issues in an ...
(Date:12/22/2014)... Fertility Associates of Memphis has announced ... , a network of more than 20 contributing ... have fast access to a national pool of frozen ... Fertility Associates of Memphis is the only fertility clinic ... , Dr. William Kutteh , director of Fertility ...
Breaking Biology Technology:Major Pipette Distributor Pipette.com Announces their Holiday in the Lab Contest 2Rock Creek Pharmaceuticals Files Clinical Trial Application in the UK for Clinical Trials of Anatabine Citrate Formulations 2Rock Creek Pharmaceuticals Files Clinical Trial Application in the UK for Clinical Trials of Anatabine Citrate Formulations 3ALNE Announces Intention To Acquire BioTechPharma 2Fertility Associates of Memphis Announces Partnership with Donor Egg Bank USA 2Fertility Associates of Memphis Announces Partnership with Donor Egg Bank USA 3
... , , , BEIJING , Feb. 8 ... in-vitro,diagnostic ("IVD") company, today announced that it will participate at the,following investor conferences in March 2010 : ... Location, ... Hotel, China Investment ...
... , NEW YORK , Feb. 8 ... relations and corporate communications for domestic and international clients, announced ... have joined as Managing Directors. , “Lisa and ... serve our clients well,” said Lynn Morgen , co-founder ...
... , , , , ... 3SBio Inc. (Nasdaq:, SSRX ) ("3SBio" or "the Company"), ... developing, manufacturing and marketing,biopharmaceutical products, today announced a collaboration ... commercialize its,Nephoxil(R) pharmaceutical product for the treatment of hyperphosphatemia ...
Cached Biology Technology:China Medical Technologies to Participate Investor Conferences in March 2010 2MBS Value Partners Hires Two New Senior Staff Members 23SBio and Panacor Bioscience Enter Collaboration and License Agreement to Develop and Commercialize Nephoxil(R) for Hyperphosphatemia 23SBio and Panacor Bioscience Enter Collaboration and License Agreement to Develop and Commercialize Nephoxil(R) for Hyperphosphatemia 33SBio and Panacor Bioscience Enter Collaboration and License Agreement to Develop and Commercialize Nephoxil(R) for Hyperphosphatemia 4
(Date:12/19/2014)... Dec. 18, 2014 Research and Markets ... "Micro Market Monitor: North America Perimeter Security Systems ... http://photos.prnewswire.com/prnh/20130307/600769 The North American ... CAGR of 3.6% from 2014 to 2019. Although the ... Canada is expected to grow ...
(Date:12/17/2014)... 15, 2014  HITLAB SM announced today ... audit to confirm its adherence to current U.S. ... enables HITLAB to conduct regulated smart device and ... for patient safety and research quality. ... quality, and delivery with innovative technology," said ...
(Date:12/11/2014)... DUBLIN , Dec. 09, 2014 Research ... http://photos.prnewswire.com/prnh/20130307/600769 ( http://www.researchandmarkets.com/research/twhjll/biometrics_market ) ... Market in the APAC Region 2015-2019"  report to ... emerging in this market is advances in technology. ... to upgrade biometric solutions to the latest standard ...
Breaking Biology News(10 mins):Micro Market Monitor: North America Perimeter Security Systems Market (Intrusion Detection Sensor, Video Surveillance, Communication/Alarm and Notification, Access Control System) 2Micro Market Monitor: North America Perimeter Security Systems Market (Intrusion Detection Sensor, Video Surveillance, Communication/Alarm and Notification, Access Control System) 3HITLAB Completes GCP Audit for FDA Smart Device & App Compliance 2Biometrics Market in the APAC Region 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2
... infected with human immunodeficiency virus (HIV), highly active ... of Kaposi sarcoma and non-Hodgkin lymphoma, according to ... of the Journal of the National Cancer Institute. ... (AIDS) have reported increased risks of several cancers, ...
... short pulses is a promising, non-invasive procedure for ... healthy tissue, according to a study in the ... focused ultrasound (HIFU) is more powerful than standard ... continuous exposures that raise the temperature inside cancerous ...
... the NIH new policy from yesterday : ... rule on Enhanced Public Access to NIH Research Information ... opportunity to take advantage of available technology and existing ... not-for-profit medical and scientific publishers. The final rule ignores ...
Cached Biology News:Antiretroviral therapy may prevent excess risk of some cancers in people with HIV 2Pulsating ultrasound enhances gene therapy for tumors 2Not-for-profit publishers call NIH public access rule a missed opportunity 2Not-for-profit publishers call NIH public access rule a missed opportunity 3
Request Info...
... The Zero Blunt ... for Sequencing is designed ... sequencing of blunt-end PCR ... provides 5-minute TOPO Cloning ...
... 1 kit. Convenient way to ... Conjugations are carried out under mild conditions ... Dyes are packaged in premeasured amounts and ... Category: Blotting & Labeling & Detection, Protein ...
...
Biology Products: